Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 3;9(6):e16977.
doi: 10.1016/j.heliyon.2023.e16977. eCollection 2023 Jun.

Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases

Affiliations
Review

Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases

Mohammad Javad Mousavi et al. Heliyon. .

Abstract

Systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc) are the most common rheumatic autoimmune diseases/disorders (RADs) that affect autologous connective tissues as a result of the breakdown of the self-tolerance mechanisms of the immune system. Prolactin, a glycoprotein hormone, has been known for its crucial role in the pathogenesis of these rheumatic autoimmune diseases. In addition to regulating lymphocyte proliferation and antibody synthesis, prolactin is also responsible for regulating cytokine production. Moreover, it contributes to the breakdown of central and peripheral tolerance mechanisms of B lymphocytes. Given the crucial role of prolactin in the pathogenesis of the mentioned RADs, prolactin may contribute to their pathogenesis by the breakdown of tolerance. In the present study, the key role of prolactin to the breakdown of B lymphocyte tolerance and its possible implication for the pathogenesis of these diseases is discussed. Current literature supports prolactin's role in the breakdown of B lymphocyte central and peripheral tolerance mechanisms, such apoptosis, receptor editing, and also anergy. Therefore, prolactin may contribute to the pathogenesis of RADs by the breakdown of B lymphocyte tolerance. However, more investigations, particularly in RA and SSc animal models, are required to precisely address the pathologic role of prolactin.

Keywords: Autoimmune disease; B lymphocyte; B lymphocyte tolerance; Prolactin; Rheumatic autoimmune disease; Tolerance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
A schematic representation of V(D)J recombination process for the generation of V(D)J exon. During the V(D)J recombination process, one V gene segment, one D gene segment (if it exists in the gene locus), and one J gene segment are randomly selected and rearranged to form a V(D)J exon. The rearranged V(D)J exon encodes the variable region of the antigenic receptor in B lymphocyte. D: diversity; J: joining; V: variable.
Fig. 2
Fig. 2
Tolerance mechanisms of B lymphocytes and their breakdown by prolactin. A. Central tolerance mechanisms of B lymphocytes B. Peripheral tolerance mechanisms of B lymphocytes.

Similar articles

Cited by

References

    1. Struman I., et al. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 1999;96(4):1246–1251. - PMC - PubMed
    1. Clapp C., et al. Regulation of blood vessels by prolactin and vasoinhibins. Adv. Exp. Med. Biol. 2015;846:83–95. - PubMed
    1. Bewley T.A., Li C.H. Circular dichroism studies on human pituitary growth hormone and ovine pituitary lactogenic hormone. Biochemistry. 1972;11(5):884–888. - PubMed
    1. Goffin V., Martial J.A., Summers N.L. Use of a model to understand prolactin and growth hormone specificities. Protein Eng. Des. Sel. 1995;8(12):1215–1231. - PubMed
    1. Radhakrishnan A., et al. A pathway map of prolactin signaling. Journal of cell communication and signaling. 2012;6(3):169–173. - PMC - PubMed

LinkOut - more resources